Bajaj HealthCare Limited (BAJAJHCARE.NS)
INR 569.3
(-4.08%)
INR 569.3
(-4.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 3.29 Billion INR | -17.01% |
| 2022 | 3.97 Billion INR | 56.04% |
| 2021 | 2.54 Billion INR | 52.88% |
| 2020 | 1.66 Billion INR | 92.06% |
| 2019 | 867.67 Million INR | 19.08% |
| 2018 | 728.64 Million INR | -6.86% |
| 2017 | 782.29 Million INR | 5.53% |
| 2016 | 741.3 Million INR | -8.32% |
| 2015 | 808.6 Million INR | 37.58% |
| 2014 | 587.71 Million INR | -5.07% |
| 2013 | 619.08 Million INR | -2.45% |
| 2012 | 634.61 Million INR | 21.25% |
| 2011 | 523.38 Million INR | 26.22% |
| 2010 | 414.67 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 3.29 Billion INR | 3090.91% |
| 2023 FY | 3.29 Billion INR | -17.01% |
| 2023 Q1 | 177.2 Million INR | -95.54% |
| 2023 Q3 | 103.38 Million INR | -97.06% |
| 2023 Q2 | 3.51 Billion INR | 1883.2% |
| 2022 Q2 | 3.21 Billion INR | 16155.24% |
| 2022 Q1 | 19.75 Million INR | -99.22% |
| 2022 FY | 3.97 Billion INR | 56.04% |
| 2022 Q4 | 3.97 Billion INR | 2846.89% |
| 2022 Q3 | 134.89 Million INR | -95.8% |
| 2021 FY | 2.54 Billion INR | 52.88% |
| 2021 Q3 | 18.04 Million INR | -99.14% |
| 2021 Q1 | 142.41 Million INR | -91.45% |
| 2021 Q2 | 2.1 Billion INR | 1374.94% |
| 2021 Q4 | 2.54 Billion INR | 14018.08% |
| 2020 Q2 | 1.05 Billion INR | 2436.71% |
| 2020 Q4 | 1.66 Billion INR | 2130.25% |
| 2020 FY | 1.66 Billion INR | 92.06% |
| 2020 Q1 | 41.58 Million INR | -95.21% |
| 2020 Q3 | 74.72 Million INR | -92.92% |
| 2019 Q2 | 681.11 Million INR | 766.39% |
| 2019 FY | 867.67 Million INR | 19.08% |
| 2019 Q4 | 867.67 Million INR | 1159.19% |
| 2019 Q3 | 68.9 Million INR | -89.88% |
| 2019 Q1 | 78.61 Million INR | -89.21% |
| 2018 Q4 | 728.64 Million INR | 0.0% |
| 2018 Q2 | 833.74 Million INR | 0.0% |
| 2018 Q3 | 728.64 Million INR | -12.61% |
| 2018 FY | 728.64 Million INR | -6.86% |
| 2018 Q1 | 833.74 Million INR | 6.58% |
| 2017 Q1 | 685.15 Million INR | -7.57% |
| 2017 Q2 | 685.15 Million INR | 0.0% |
| 2017 Q3 | 782.29 Million INR | 14.18% |
| 2017 Q4 | 782.29 Million INR | 0.0% |
| 2017 FY | 782.29 Million INR | 5.53% |
| 2016 Q3 | 741.3 Million INR | 6.24% |
| 2016 Q2 | 697.75 Million INR | 0.0% |
| 2016 Q4 | 741.3 Million INR | 0.0% |
| 2016 FY | 741.3 Million INR | -8.32% |
| 2016 Q1 | 697.75 Million INR | -13.71% |
| 2015 Q2 | 736.98 Million INR | 0.0% |
| 2015 Q4 | 808.6 Million INR | 12.49% |
| 2015 Q3 | 718.82 Million INR | -2.46% |
| 2015 Q1 | 736.98 Million INR | 0.0% |
| 2015 FY | 808.6 Million INR | 37.58% |
| 2014 FY | 587.71 Million INR | -5.07% |
| 2013 FY | 619.08 Million INR | -2.45% |
| 2012 FY | 634.61 Million INR | 21.25% |
| 2011 FY | 523.38 Million INR | 26.22% |
| 2010 FY | 414.67 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 14.665% |
| Bafna Pharmaceuticals Limited | 229.93 Million INR | -1334.746% |
| FDC Limited | -57.75 Million INR | 5812.278% |
| Gufic Biosciences Limited | 3.19 Billion INR | -3.276% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 87.814% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 46.422% |
| Orchid Pharma Limited | -1.31 Billion INR | 351.092% |
| Alkem Laboratories Limited | -1.6 Billion INR | 304.98% |
| Brooks Laboratories Limited | 49.48 Million INR | -6566.576% |
| Eris Lifesciences Limited | 13.8 Billion INR | 76.106% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 216.052% |
| Solara Active Pharma Sciences Limited | 10.03 Billion INR | 67.115% |
| Innova Captab Limited | 2.33 Billion INR | -41.358% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 337.347% |
| Wanbury Limited | 1.1 Billion INR | -198.312% |
| Lupin Limited | 19.38 Billion INR | 82.982% |
| Aarti Drugs Limited | 5.54 Billion INR | 40.542% |
| Aarti Pharmalabs Limited | 2.61 Billion INR | -26.305% |
| Albert David Limited | -278.36 Million INR | 1285.101% |
| Alembic Limited | 66.9 Million INR | -4831.173% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 17984.392% |
| Hester Biosciences Limited | 2.29 Billion INR | -44.013% |
| Hikal Limited | 7.96 Billion INR | 58.592% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 179.434% |
| Ind-Swift Limited | 9.5 Billion INR | 65.306% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 399.551% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -2648.236% |
| Lincoln Pharmaceuticals Limited | -127.63 Million INR | 2684.618% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -238.073% |
| Medico Remedies Limited | 78.67 Million INR | -4093.036% |
| Morepen Laboratories Limited | -231.17 Million INR | 1527.044% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 240.501% |
| RPG Life Sciences Limited | -364.7 Million INR | 1004.567% |
| Sigachi Industries Limited | 859.94 Million INR | -283.622% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 104.552% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -2175.518% |
| Themis Medicare Limited | 764.96 Million INR | -331.257% |
| Unichem Laboratories Limited | 931.91 Million INR | -253.997% |
| Vaishali Pharma Limited | 119.13 Million INR | -2669.09% |
| Venus Remedies Limited | -267.7 Million INR | 1332.333% |
| Windlas Biotech Limited | -273.04 Million INR | 1308.231% |
| ZIM Laboratories Limited | 983.6 Million INR | -235.395% |
| Sakar Healthcare Limited | 790.93 Million INR | -317.095% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 10.677% |
| Divi's Laboratories Limited | -39.77 Billion INR | 108.295% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 165.815% |
| Mankind Pharma Limited | -1.74 Billion INR | 288.69% |
| Sequent Scientific Limited | 4.17 Billion INR | 21.052% |
| Laurus Labs Limited | 24.35 Billion INR | 86.456% |
| Neuland Laboratories Limited | -214.05 Million INR | 1641.15% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | -16.934% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 176.984% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 15.671% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 1425.989% |
| Wockhardt Limited | 18.27 Billion INR | 81.943% |
| Bal Pharma Limited | 1.26 Billion INR | -161.084% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 74.452% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 384.945% |
| Par Drugs and Chemicals Limited | -366.53 Million INR | 1000.028% |
| Caplin Point Laboratories Limited | -5.5 Billion INR | 159.897% |
| Shilpa Medicare Limited | 9.06 Billion INR | 63.626% |
| Valiant Laboratories Limited | 649.9 Million INR | -407.608% |
| Ajanta Pharma Limited | -954.9 Million INR | 445.476% |
| Aarey Drugs & Pharmaceuticals Limited | 297.57 Million INR | -1008.597% |
| Granules India Limited | 9.28 Billion INR | 64.477% |
| Medicamen Biotech Limited | 160.31 Million INR | -1957.783% |
| Ipca Laboratories Limited | 11.41 Billion INR | 71.1% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -7038.896% |
| Piramal Enterprises Limited | 491.39 Billion INR | 99.329% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 89.636% |
| NATCO Pharma Limited | -5.81 Billion INR | 156.712% |
| Suven Life Sciences Limited | -1.63 Billion INR | 302.055% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -70.672% |
| Strides Pharma Science Limited | 23.25 Billion INR | 85.815% |
| Indoco Remedies Limited | 6.47 Billion INR | 49.061% |
| Alpa Laboratories Limited | 35.36 Million INR | -9228.832% |
| Lasa Supergenerics Limited | 205.79 Million INR | -1502.999% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 450.282% |